Wright Medical Group, Inc. Announces FDA Approval for AUGMENT(R) Bone Graft
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Northland Capital Markets Remains Bullish on Wright Medical Group (WMGI) Following AUGMENT FDA Approval
September 2, 2015 9:40 AM EDTNorthland Capital Markets reiterated an Outperform rating and $32.00 price target on Wright Medical (NASDAQ: WMGI) following FDA approval of AUGMENT in hindfoot and ankle fusion with a clean label.
Analyst Mark Landy commented, "Yesterday WMGI announced FDA approval of AUGMENT in... More
Wright Medical (WMGI) Augment Approval Removes Overhang, Leerink Partners Says
September 2, 2015 6:24 AM EDTLeerink Partners analyst Richard Newitter reiterated an Outperform rating and $31 price target on Wright Medical (NASDAQ: WMGI), saying Augment approval unlocks a key growth catalyst and removes an overhang.
Newitter commented, "We expect WMGI shares to react positively following FDA... More
Wright Medical Group's (WMGI) AUGMENT Bone Graf PMA Receives FDA Approal
September 1, 2015 4:14 PM EDTWright Medical Group (NASDAQ: WMGI) announced that its BioMimetic subsidiary has received an approval order from the U.S. Food and Drug Administration (FDA) for its Premarket Approval Application (PMA) for AUGMENT Bone Graft. The approval order indicates that FDA determined that AUGMENT® Bone Graft is safe and effective as an alternative to autograft for ankle and/or hindfoot fusion indications. Wright can now initiate commercial sale and distribution of AUGMENT® Bone Graft in the U.S.
Robert Palmisano, president and chief executive officer, stated, The FDA approval of AUGMENT marks a capstone... More
Wright Medical Group (WMGI) Reports FDA Approval of AUGMENT Bone Graft
September 1, 2015 4:13 PM EDTWright Medical Group, Inc. (NASDAQ: WMGI) today announced that its BioMimetic subsidiary has received an approval order from the U.S. Food and Drug Administration (FDA) for its Premarket Approval Application (PMA) for AUGMENT® Bone Graft. The approval order indicates that FDA determined that AUGMENT® Bone Graft is safe and effective as an alternative to autograft for ankle and/or hindfoot fusion indications. Wright can now initiate commercial sale and distribution of AUGMENT® Bone Graft in the U.S.
Robert Palmisano, president and chief executive officer, stated, The FDA approval of AUGMENT marks a capstone... More
